AL
SCLN

AJO LP’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

AJO LP’s Portfolio SCLN Stock Details SCLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-218,306
Closed -$2.4M – 554
2016
Q1 		$2.4M Sell
218,306
-14,790
-6% -$132K 0.01% 331
2015
Q4 		$2.14M Sell
233,096
-51,836
-18% -$434K 0.01% 365
2015
Q3 		$1.98M Buy
284,932
+215,642
+311% +$1.85M 0.01% 360
2015
Q2 		$680K Sell
69,290
-7,310
-10% -$66.6K ﹤0.01% 457
2015
Q1 		$679K Hold
76,600
– – ﹤0.01% 424
2014
Q4 		$671K Hold
76,600
– – ﹤0.01% 396
2014
Q3 		$528K Buy
+76,600
New +$459K ﹤0.01% 376
2013
Q4 		– Sell
-956,000
Closed -$4.85M – 544
2013
Q3 		$4.85M Buy
956,000
+638,300
+201% +$3.55M 0.02% 285
2013
Q2 		$1.58M Buy
+317,700
New +$1.51M 0.01% 388

Other funds holding SCLN

Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

AJO LP's SCLN Position: Q2 2016 in Review

AJO LP sold out of Sciclone Pharmaceuticals Inc (SCLN) in Q2 2016, closing a stake of 218,306 shares — an estimated $2.4M sold.

AJO LP first reported a position in SCLN in Q2 2013 and held it in 9 quarters. The position peaked at $4.85M in Q3 2013. 151 funds tracked by Wall St. Rank hold SCLN as of Q2 2016.

  • AJO LP reported no remaining Sciclone Pharmaceuticals Inc position as of Q2 2016 after selling out during the quarter.
  • AJO LP sold 218,306 Sciclone Pharmaceuticals Inc shares in Q2 2016, an estimated $2.4M.
  • AJO LP first reported a position in Sciclone Pharmaceuticals Inc in Q2 2013 and held it in 9 quarters.
  • AJO LP's Sciclone Pharmaceuticals Inc position peaked at $4.85M in Q3 2013.
  • 151 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals Inc as of Q2 2016.

Based on AJO LP's 13F filing for Q2 2016, filed 9 Aug 2016.